Investors Analyst Coverage Banca/SIM Analyst Banca Akros Paola Saglietti +39 02 43444287 Banca IMI Bruno Permutti +39 02 87949819 Barclays Brian Balchin +44 20 31340137 Credit Suisse European Pharmaceuticals Equity Research +44 20 78880304 Deutsche Bank Rajan Sharma +44 20 75453663 Equita SIM Martino De Ambroggi +39 02 6204238 Goldman Sachs Keyur Parekh +44 20 75529939 Intermonte Giorgio Tavolini +39 02 77115279 Jefferies International Ltd. James Vane-Tempest +44 20 70298275 J.P. Morgan Cazenove James D Gordon +44 20 77426654 Kepler Chevreux Niccolò Guido Storer +39 02 85507209 Mediobanca Isacco Brambilla +39 02 8829067 Oddo Securities Martial Descoutures +33 1 55354248 Annual Report Corporate Brochure The Prize Alert Service Italiano | English Company data RECORDATI S.p.A. VIA M. CIVITALI, 1 - 20148 MILAN, ITALY SHARE CAPITAL € 26.140.644,5 i.v. REG. IMP. MILANO, MONZA, BRIANZA e LODI 00748210150 CODICE FISCALE/P. IVA 00748210150 R.E.A. MILANO 401832 Company subject to the Management and Coordination Activities of Rossini Luxembourg S.àr.l delivered by Tech Style Site Services Alert Services Legal Notice Privacy Policy Latest News 29 October 2021 RECORDATI: SHARE BUY-BACK PROGRAM TO SERVICE THE STOCK OPTION PLANS 28 October 2021 RECORDATI: 2021 FIRST NINE MONTHS RESULTS APPROVED. REVENUE +5.7%, EBITDA +2.1% AND NET INCOME +8.1%. THE RECOVERY BEGUN IN THE SECOND QUARTER CONTINUES

Investors Key Financial data Balance Sheet Structure Annual Report Corporate Brochure The Prize Alert Service Italiano | English Company data RECORDATI S.p.A. VIA M. CIVITALI, 1 - 20148 MILAN, ITALY SHARE CAPITAL € 26.140.644,5 i.v. REG. IMP. MILANO, MONZA, BRIANZA e LODI 00748210150 CODICE FISCALE/P. IVA 00748210150 R.E.A. MILANO 401832 Company subject to the Management and Coordination Activities of Rossini Luxembourg S.àr.l delivered by Tech Style Site Services Alert Services Legal Notice Privacy Policy Latest News 29 October 2021 RECORDATI: SHARE BUY-BACK PROGRAM TO SERVICE THE STOCK OPTION PLANS 28 October 2021 RECORDATI: 2021 FIRST NINE MONTHS RESULTS APPROVED. REVENUE +5.7%, EBITDA +2.1% AND NET INCOME +8.1%. THE RECOVERY BEGUN IN THE SECOND QUARTER CONTINUES